Literature DB >> 27468190

Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy.

Mhairi C Donnelly1, Peter C Hayes1, Kenneth J Simpson1.   

Abstract

Acute liver failure is a rare and devastating clinical condition. At present, emergency liver transplantation is the only life-saving therapy in advanced cases, yet the feasibility of transplantation is affected by the presence of systemic inflammation, infection and resultant multi-organ failure. The importance of immune dysregulation and acquisition of infection in the pathogenesis of acute liver failure and its associated complications is now recognised. In this review we discuss current thinking regarding the role of infection and inflammation in the pathogenesis of and outcome in human acute liver failure, the implications for the management of such patients and suggest directions for future research.

Entities:  

Keywords:  Acute liver failure; Biomarker; Infection; Inflammation; Neuroinflammation

Mesh:

Substances:

Year:  2016        PMID: 27468190      PMCID: PMC4948263          DOI: 10.3748/wjg.v22.i26.5958

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  80 in total

Review 1.  Mechanisms of hepatotoxicity.

Authors:  Hartmut Jaeschke; Gregory J Gores; Arthur I Cederbaum; Jack A Hinson; Dominique Pessayre; John J Lemasters
Journal:  Toxicol Sci       Date:  2002-02       Impact factor: 4.849

Review 2.  Infectious complications of acute and chronic liver disease.

Authors:  Bettina Leber; Walter Spindelboeck; Vanessa Stadlbauer
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

3.  N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms.

Authors:  Chantal Bémeur; Javier Vaquero; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2010-04-30       Impact factor: 3.584

4.  Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.

Authors:  S P Wilkinson; V Arroyo; B G Gazzard; H Moodie; R Williams
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

5.  Plasma osteopontin in acute liver failure.

Authors:  Praveen Srungaram; Jody A Rule; He Jun Yuan; Andreas Reimold; Benny Dahl; Corron Sanders; William M Lee
Journal:  Cytokine       Date:  2015-03-21       Impact factor: 3.861

6.  Opportunistic infection in patients with acute liver failure.

Authors:  Makoto Arai; Tatsuo Kanda; Shin Yasui; Keiichi Fujiwara; Fumio Imazeki; Akira Watanabe; Takeyuki Sato; Shigeto Oda; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-01-24       Impact factor: 6.047

7.  Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure.

Authors:  Alexander Koch; Henning W Zimmermann; Nikolaus Gassler; Christoph Jochum; Ralf Weiskirchen; Jan Bruensing; Lukas Buendgens; Hanna Dückers; Tony Bruns; Guido Gerken; Ulf P Neumann; David H Adams; Christian Trautwein; Ali Canbay; Frank Tacke
Journal:  Liver Int       Date:  2014-03-19       Impact factor: 5.828

8.  Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow.

Authors:  Rajiv Jalan; Steven W M Olde Damink; Peter C Hayes; Nicolaas E P Deutz; Alistair Lee
Journal:  J Hepatol       Date:  2004-10       Impact factor: 25.083

9.  Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure.

Authors:  Keiichi Fujiwara; Shin Yasui; Yutaka Yonemitsu; Makoto Arai; Tatsuo Kanda; Yoshihiro Fukuda; Masayuki Nakano; Shigeto Oda; Osamu Yokosuka
Journal:  J Hepatobiliary Pancreat Sci       Date:  2016-02-21       Impact factor: 7.027

10.  Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia.

Authors:  Wenlei Jiang; Paul Desjardins; Roger F Butterworth
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-04       Impact factor: 6.200

View more
  12 in total

1.  Hepatoprotective functions of jujuboside B.

Authors:  Chaeyeong Kim; Yun Hee Jeong; Nayeon Kim; Soo Ho Ryu; Jong-Sup Bae
Journal:  J Nat Med       Date:  2022-09-06       Impact factor: 3.192

Review 2.  Therapeutic plasma exchange in children with acute liver failure (ALF): is it time for incorporation into the ALF armamentarium?

Authors:  Emma C Alexander; Akash Deep
Journal:  Pediatr Nephrol       Date:  2021-10-14       Impact factor: 3.651

3.  Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report.

Authors:  Matthias Buechter; Guido Gerken; Dieter P Hoyer; Stefanie Bertram; Jens M Theysohn; Viktoria Thodou; Alisan Kahraman
Journal:  BMC Anesthesiol       Date:  2018-06-20       Impact factor: 2.217

4.  Mesenchymal Stem Cells Improve Glycometabolism and Liver Regeneration in the Treatment of Post-hepatectomy Liver Failure.

Authors:  Hao-Ran Ding; Jing-Lin Wang; Zhen-Ting Tang; Yue Wang; Guang Zhou; Yang Liu; Hao-Zhen Ren; Xiao-Lei Shi
Journal:  Front Physiol       Date:  2019-04-10       Impact factor: 4.566

Review 5.  Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis.

Authors:  Juan Li; Ying-Ren Zhao; Zhen Tian
Journal:  World J Hepatol       Date:  2019-05-27

6.  Poly(Ethylene Glycol) Crosslinked Multi-Armed Poly(l-Lysine) with Encapsulating Capacity and Antimicrobial Activity for the Potential Treatment of Infection-Involved Multifactorial Diseases.

Authors:  Chao Lu; Ting Wen; Maochao Zheng; Daojun Liu; Guilan Quan; Xin Pan; Chuanbin Wu
Journal:  Pharmaceutics       Date:  2020-01-06       Impact factor: 6.321

7.  The Toll of Hyperammonemia on the Brain.

Authors:  Justin M Saunders; Javier González-Maeso; Jasmohan S Bajaj
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-09-16

8.  Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure.

Authors:  Xueliang Yang; Yunru Chen; Jian Zhang; Tiantian Tang; Ying Kong; Feng Ye; Xi Zhang; Xiaojing Liu; Shumei Lin
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

Review 9.  Perspective of placenta derived mesenchymal stem cells in acute liver failure.

Authors:  Mahshid Saleh; Mohammad Taher; Amir Ali Sohrabpour; Amir Abbas Vaezi; Mohsen Nasiri Toosi; Maria Kavianpour; Zeinab Ghazvinian; Shahrokh Abdolahi; Javad Verdi
Journal:  Cell Biosci       Date:  2020-05-24       Impact factor: 7.133

10.  Probiotic Lactobacillus casei Shirota prevents acute liver injury by reshaping the gut microbiota to alleviate excessive inflammation and metabolic disorders.

Authors:  Ren Yan; Kaicen Wang; Qiangqiang Wang; Huiyong Jiang; Yingfeng Lu; Xiaoxiao Chen; Hua Zhang; Xiaoling Su; Yiling Du; Lifeng Chen; Lanjuan Li; Longxian Lv
Journal:  Microb Biotechnol       Date:  2021-01-25       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.